Matches in Wikidata for { <http://www.wikidata.org/entity/Q95930265> ?p ?o ?g. }
- Q95930265 description "2020 nî lūn-bûn" @default.
- Q95930265 description "2020年の論文" @default.
- Q95930265 description "2020年学术文章" @default.
- Q95930265 description "2020年学术文章" @default.
- Q95930265 description "2020年学术文章" @default.
- Q95930265 description "2020年学术文章" @default.
- Q95930265 description "2020年学术文章" @default.
- Q95930265 description "2020年学术文章" @default.
- Q95930265 description "2020年學術文章" @default.
- Q95930265 description "2020年學術文章" @default.
- Q95930265 description "2020年學術文章" @default.
- Q95930265 description "2020年學術文章" @default.
- Q95930265 description "2020年學術文章" @default.
- Q95930265 description "2020년 논문" @default.
- Q95930265 description "article científic" @default.
- Q95930265 description "article scientific" @default.
- Q95930265 description "article scientifique" @default.
- Q95930265 description "articol științific" @default.
- Q95930265 description "articolo scientifico" @default.
- Q95930265 description "artigo científico" @default.
- Q95930265 description "artigo científico" @default.
- Q95930265 description "artigo científico" @default.
- Q95930265 description "artikel ilmiah" @default.
- Q95930265 description "artikull shkencor" @default.
- Q95930265 description "artikulong pang-agham" @default.
- Q95930265 description "artykuł naukowy" @default.
- Q95930265 description "artículo científico publicado en 2020" @default.
- Q95930265 description "artículu científicu" @default.
- Q95930265 description "bilimsel makale" @default.
- Q95930265 description "bài báo khoa học" @default.
- Q95930265 description "naučni članak" @default.
- Q95930265 description "scienca artikolo" @default.
- Q95930265 description "scientific article published on 24 May 2020" @default.
- Q95930265 description "scientific article published on 24 May 2020" @default.
- Q95930265 description "scientific article published on 24 May 2020" @default.
- Q95930265 description "teaduslik artikkel" @default.
- Q95930265 description "tieteellinen artikkeli" @default.
- Q95930265 description "tudományos cikk" @default.
- Q95930265 description "vedecký článok" @default.
- Q95930265 description "vetenskaplig artikel" @default.
- Q95930265 description "videnskabelig artikel udgivet 24. maj 2020" @default.
- Q95930265 description "vitenskapelig artikkel" @default.
- Q95930265 description "vitskapeleg artikkel" @default.
- Q95930265 description "vědecký článek" @default.
- Q95930265 description "wetenschappelijk artikel" @default.
- Q95930265 description "wissenschaftlicher Artikel" @default.
- Q95930265 description "επιστημονικό άρθρο" @default.
- Q95930265 description "мақолаи илмӣ" @default.
- Q95930265 description "наукова стаття, опублікована в травні 2020" @default.
- Q95930265 description "научна статия" @default.
- Q95930265 description "научная статья" @default.
- Q95930265 description "научни чланак" @default.
- Q95930265 description "научни чланак" @default.
- Q95930265 description "מאמר מדעי" @default.
- Q95930265 description "مقالة علمية نشرت في 24 مايو 2020" @default.
- Q95930265 description "২৪ মে ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q95930265 description "บทความทางวิทยาศาสตร์" @default.
- Q95930265 description "სამეცნიერო სტატია" @default.
- Q95930265 name "Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases" @default.
- Q95930265 name "Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases" @default.
- Q95930265 type Item @default.
- Q95930265 label "Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases" @default.
- Q95930265 label "Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases" @default.
- Q95930265 prefLabel "Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases" @default.
- Q95930265 prefLabel "Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases" @default.
- Q95930265 P1433 Q95930265-3F1EB783-1E02-4343-8D6F-517F56D0425E @default.
- Q95930265 P1476 Q95930265-A3E57C5C-6163-42B0-B93B-E9FE75417EDC @default.
- Q95930265 P2093 Q95930265-152B45BA-350C-427C-9A67-A3A1539DAD3C @default.
- Q95930265 P2093 Q95930265-1A7EEF2A-4E3D-4583-A313-1194D65BEB50 @default.
- Q95930265 P2093 Q95930265-222F5460-2D17-487B-B2DA-A636BAED59E8 @default.
- Q95930265 P2093 Q95930265-33D2BD35-1FCE-4AD8-AE60-225D2136B987 @default.
- Q95930265 P2093 Q95930265-673C2F6B-F85D-4328-ADD2-B8780C592081 @default.
- Q95930265 P2093 Q95930265-80F9F738-E23A-410D-9170-2BF3830EA7A0 @default.
- Q95930265 P2093 Q95930265-8DB4D708-F1FD-49CA-9DB1-0B8075DC763D @default.
- Q95930265 P2093 Q95930265-9398728D-F140-430A-A2D9-253237789E03 @default.
- Q95930265 P2093 Q95930265-A44300CC-F698-4AE0-8AB2-6FEEE8A40E4A @default.
- Q95930265 P2093 Q95930265-AA02EC42-8B0A-4FCC-BE4E-A2ABA80D5C77 @default.
- Q95930265 P2093 Q95930265-B93A8FA5-1487-45AD-B417-74D24D79CD33 @default.
- Q95930265 P31 Q95930265-D1D0C5CF-A3D0-442A-8009-DF68A38DA400 @default.
- Q95930265 P356 Q95930265-69AA4C45-91A9-4483-9C22-057D71C33D16 @default.
- Q95930265 P50 Q95930265-1EE2E35D-31F1-48D0-8D37-9CF4DED217AF @default.
- Q95930265 P50 Q95930265-8B8606F5-F081-4439-B86A-0B74B6E3C78C @default.
- Q95930265 P50 Q95930265-CCF50433-74A3-4247-B568-67FC68ACC878 @default.
- Q95930265 P577 Q95930265-8B28B69E-D3D6-4BBA-BDAC-1DECDC3AD749 @default.
- Q95930265 P698 Q95930265-9F863BDB-1E0B-433D-A243-57164836576E @default.
- Q95930265 P921 Q95930265-6FA41774-4E5F-42E0-94B3-CD74D8A79148 @default.
- Q95930265 P921 Q95930265-76649DEE-624C-4AB3-A91A-CA9AD0069F7E @default.
- Q95930265 P921 Q95930265-D8C0EEBA-E28C-4FEC-86D3-757772659FEA @default.
- Q95930265 P356 J.ANNONC.2020.05.014 @default.
- Q95930265 P698 32461105 @default.
- Q95930265 P1433 Q326122 @default.
- Q95930265 P1476 "Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases" @default.
- Q95930265 P2093 "E Lawler" @default.
- Q95930265 P2093 "I Krop" @default.
- Q95930265 P2093 "J P Leone" @default.
- Q95930265 P2093 "J Younger" @default.
- Q95930265 P2093 "L Trippa" @default.
- Q95930265 P2093 "L Walker" @default.
- Q95930265 P2093 "O Metzger" @default.
- Q95930265 P2093 "R A Freedman" @default.